Secretory IgA against pertussis toxin and surface structures of Bordetella pertussis in saliva of children with culture proven pertussis
Frühwirth, M.; Wolf, H.; Heininger, H.; Guggenbichler, J.P.; Stehr, E.
Advances in Experimental Medicine and Biology 371b: 777-783
1995
ISSN/ISBN: 0065-2598 PMID: 7502896 Document Number: 444959
Document emailed within 1 workday
Related Documents
Siundiukova, R.A.; Basnak'ian, I.A.; Stukalova, N.V.; Aleksakhina, N.N. 1999: The effect of methylated cyclodextrin on pertussis toxin accumulation in a Bordetella pertussis culture in a bioreactor Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 14-17Chodorowska, M. 1999: Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough Medycyna Doswiadczalna i Mikrobiologia 51(3-4): 269-280
Siniashina, L.N.; Siniashina, L.S.; Semin, E.G.; Amelina, I.P.; Karataev, G.I. 2010: Construction of the genetically attenuated bacteria Bordetella pertussis devoid of dermonecrotic toxin activity and producing modified nontoxic pertussis toxin form Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 3: 31-36
Lau, R.C. 1989: Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population New Zealand Medical Journal 102(878): 560-562
Rastawicki, W.; Smietańska, K.; Rokosz-Chudziak, N.; Jagielski, M. 2013: Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough Medycyna Doswiadczalna i Mikrobiologia 65(4): 269-274
Blumberg, D.A.; Pineda, E.; Cherry, J.D.; Caruso, A.; Scott, J.V. 1992: The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis--strain dependent American Journal of Diseases of Children 146(10): 1148-1150
Kanaho, Y.; Stadel, J.M.; Huang, C.K.; Becker, E.L. 1988: Biochemical discrimination of the predominant pertussis toxin substrate of rabbit neutrophils from brain Gi and Go: isoelectric focusing improves resolution of pertussis toxin substrates Biochemistry International 16(5): 879-886
Schneerson, R.; Robbins, J.B.; Taranger, J.; Lagerård, T.; Trollfors, B. 1997: Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis Developments in Biological Standardization 89: 321-326
Mills, K.H.; Brady, M.; Ryan, E.; Mahon, B.P. 1998: A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity Developments in Biological Standardization 95: 31-41
Finger, H.; Hof, H.; Plager, L.; Elekes, E. 1973: Influence of Bordetella pertussis on the lymphatic tissue of mice IX. Studies on the participation of lymph nodes in the immune response of mice to sheep erythrocytes under the influence of Bordetella pertussis Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 146(3): 207-224
Adonajlo, A.; Mazurowska-Magdzik, M.; Pstragowska, W.; Dadak, M. 1975: Effect of infectious diseases on levels of pertussis antibodies in children vaccinated against pertussis Przeglad Epidemiologiczny 29(3): 321-326
Rozinov, M.N.; Shumakov, I.L.; Daĭn, A.A.; Gol'tsmaĭer, T.A.; Gershanovich, V.N. 1988: Detection of the gene sequences of the leukocytosis (lymphocytosis)-stimulating factor of Bordetella pertussis in Bordetella parapertussis and Bordetella bronchiseptica by using molecular hybridization Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 90-93
Corbel, M. J. 1993: Developments in Biological Standardization, volume 73. Pertussis: Evaluation and Research on Acellular Pertussis Vaccines Journal of Medical Microbiology 38(2): 155-156
Isomura, S.; Suzuki, S.; Sato, Y. 1985: Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients Developments in Biological Standardization 61: 531-537
Hinman, A.R.; Koplan, J.P. 1984: Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs JAMA 251(23): 3109-3113
Shahdadpuri, R.I.; Nicholson, A.J.; Bedford, D.; O'Flanagan, D. 2004: Pertussis--going, going, but not gone: thirteen year trends in the incidence of pertussis in the Republic of Ireland and North Eastern Health Board Irish Medical Journal 97(2): 44-46
Edwards, K.M.; Lawrence, E.; Wright, P.F. 1986: Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components American Journal of Diseases of Children 140(9): 867-871
Chuprinina, R.P.; Alekseeva, I.A.; Ozeretskovskiĭ, N.A. 2006: Prophylaxis of pertussis: development and use of acellular pertussis vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2006(1): 99-105
Ozkal, A.; Sensoy, G.ül.; Acuner, C.ğa.; Belet, N.şe.; Güney, A.K. 2012: Seroprevalence of Bordetella pertussis immunoglobulin G antibodies among children in Samsun, Turkey Turkish Journal of Pediatrics 54(1): 15-19
Watanabe, M.; Sekiya, K.; Nakase, Y.; Yamada, M. 1975: Drug sensitivity of recently isolated Bordetella pertussis and Bordetella parapertussis Nihon Saikingaku Zasshi. Japanese Journal of Bacteriology 30(3): 501-505